Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NAXD Antisense RNA 1 (NAXD-AS1) is a non-coding RNA transcribed from the antisense strand of the NAXD gene locus. It belongs to the long non-coding RNA class and is categorized as a natural antisense transcript. Antisense RNAs like NAXD-AS1 are increasingly recognized as important regulators of gene expression, often by overlapping with coding gene transcripts and influencing transcription, splicing, or chromatin state[1][3][4]. NAXD-AS1 has been catalogued genomically but is not well-characterized regarding its unique cellular function, protein interactions, or disease mechanism[3]. There is no specific evidence for drug interaction, biomarker utility, or direct clinical disease association beyond the mechanistic link to its sense gene, NAXD, whose deficiency is causative for rare neurological disorders[3]. The exact biological role of NAXD-AS1 remains to be elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NAXD Antisense RNA 1 (NAXD-AS1).